The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Danaher Corporation (NYSE:DHR) stock has experienced a notable downturn, reaching a 52-week low of $225.36. With a market ...

Danaher (DHR) stock trades ~5% lower as the company, with its Q4 2024 results, projects a sales contraction in the current ...

Stifel analysts reduced the price target for Danaher Corporation shares (NYSE:DHR) to $260 from the previous target of $265, while maintaining a Hold rating on the stock. The new target sits within ...

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...

The stock of Danaher (DHR) is down about 10% after the medical device maker reported mixed results for the fourth quarter of ...

TD Cowen analyst Dan Brennan lowered the firm’s price target on Danaher (DHR) to $260 from $315 and keeps a Buy rating on the shares. The firm ...

Danaher Corporation DHR reported weaker-than-expected fourth-quarter earnings on Wednesday. The company reported fourth-quarter adjusted earnings per share of $2.14 missing the street view of $2.16.

U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Beckman Coulter Diagnostics, a ...